Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 7,165 | 8,103 | 6,726 | 7,064 | 7,846 |
| Operating Income | -7,165 | -8,103 | -6,726 | -7,064 | -7,846 |
| Interest Expense | 442 | 59 | 63 | 74 | 71 |
| Other Income | 435 | 1,023 | -469 | 632 | 67 |
| Pre-tax Income | -7,172 | -7,139 | -7,258 | -6,506 | -7,850 |
| Income Tax | N/A | N/A | -138 | -20 | -19 |
| Net Income Continuous | -7,172 | -7,139 | -7,120 | -6,486 | -7,831 |
| Net Income | $-7,172 | $-7,139 | $-7,120 | $-6,486 | $-7,831 |
| EPS Basic Total Ops | -1.48 | -1.47 | -2.28 | 289.13 | -53.74 |
| EPS Basic Continuous Ops | -1.48 | -1.47 | -2.28 | 372.82 | -53.64 |
| EPS Diluted Total Ops | -1.48 | -1.47 | -2.28 | 289.13 | -53.74 |
| EPS Diluted Continuous Ops | -1.48 | -1.47 | -2.28 | 372.82 | -53.64 |
| EPS Diluted Before Non-Recurring Items | -1.48 | -1.47 | -2.28 | -65.90 | -53.80 |
| EBITDA(a) | $-7,165 | $-8,103 | $-6,726 | $-7,064 | $-7,846 |